MASCT-I in Patients With Metastatic or Recurrent Solid Tumors Who Failed Standard Therapy.
Clinical trial NCT05877651 · COMPLETED
Trial details
- NCT number
- NCT05877651
- Sponsor
- HRYZ Biotech Co.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-21
- Primary completion
- 2021-10-15
- Enrollment
- 22
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.